RxDoctor Payments Data

Greg Horton, MD

Foot and Ankle Surgery · Kansas City, KSNPI 1396854303

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $660,000 of the $1,062,967 with a category attached, or 62.1%. Paragon 28, Inc. accounts for 62.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $685,755 and has fallen 90.1% since, to $67,914 in 2025. Among foot and ankle surgery clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,062,967in general payments, 2019–2025

Across 119 payments — averaging $8932.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$660K
  • Stryker$167K
  • Linvatec Corporation$124K
  • Arthrex$67K
  • In2bones USA, LLC$43K
  • Pylant Medical$464
  • plus $1K from 11 others
$10,750in research payments, 2019–2025

Across 1 payment — averaging $10,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$11K

What the payments were for

  • Royalty or licence$252,51224%
  • Consulting fees$37,5004%
  • Speaking & faculty fees$2,0750%
  • Travel & lodging$3,9620%
  • Food & beverage$2,1330%
  • Education$4560%
  • Ownership interest$660,00062%
  • Other$104,33010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,062,967 in reported general payments places this provider in the 95th percentile of 40 foot and ankle surgery providers in Kansas.

See all foot and ankle surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$175,575
Medicare patients
374
Services billed
1,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 4616$76,171
Gabapentin104$2,175
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$342
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$270
Oxycodone Hcl33$263
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim57$261
Mupirocin20$175
Tramadol Hcl17$43
Amoxicillin24$24
Meloxicam12$24

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →